TickerFactsScreenerDevelopers

Tvardi Therapeutics, Inc. (TVRD) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $5.0K2014: $42.0K2015: $20.0K2016: $717.0K2017: $58.0K2018: $73.0K2019: $18.0K2020: $349.0K2021: $39.0K2022: $43.0K2023: $2.38M2024: $1.05M$1.05M
2013Capital Expenditures (USD)2024
Fiscal YearCapital ExpendituresChange YoY
2024$1.05M-56.0%
2023$2.38M+5423.3%
2022$43.0K+10.3%
2021$39.0K-88.8%
2020$349.0K+1838.9%
2019$18.0K-75.3%
2018$73.0K+25.9%
2017$58.0K-91.9%
2016$717.0K+3485.0%
2015$20.0K-52.4%
2014$42.0K+740.0%
2013$5.0K—